Tetra Bio Pharma Sees Two Products Approved By Health Canada

As The Deep Dive reported on late yesterday afternoon, Tetra Bio Pharma (TSXV: TBP) has received approval from Health Canada for over the counter products. The catch, is that the company has actually received approval for two separate products from the regulator. Both products are to be marketed under the Terpacan banner.

The products, referred to as Terpacan (hemorrhoids) and Terpacan (back & muscle pain) are expected to be arriving on Canadian pharmacy shelves by mid-2020. The company is currently in the process of finalizing supply, sales, and distribution agreements with “several companies.”

Tetra Bio Pharma also anticipates on acquiring sales in international jurisdictions within 2020, which includes both the United States and Europe. Terpacan is currently waiting on final marketing approval in these regions, however they are expected to be acquired in the near term. The company currently anticipates a late year launch in the United States, where it is in the process of finalizing a manufacturing agreement.

Tetra Bio Pharma last traded at $0.56 on the TSX Venture.


Information for this briefing was found via Sedar, Health Canada and Tetra Bio-Pharma. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Endeavour Mining Q1 Earnings: Cash Flow Is King

G Mining Oko West Feasibility: Move Fast, Break.. Nothing?

New Gold Q1 Earnings: What’s Behind The Market’s Surprising Reaction?

Recommended

First Majestic Posts Record Cash Flows In Q1 As Production Costs Fall

Brazil Potash Secures Funding In Support Of US$2.5 Billion Autozales Project

Related News

Tetra Bio-Pharma Releases Update Regarding its Veterinary Clinical Study

Tetra Bio-Pharma Inc (TSXV: TBP) has released an update regarding its clinical study for the...

Wednesday, January 29, 2020, 08:55:32 AM

Market Movers: Tetra Bio-Pharma

Cannabis adjacent pharma-co Tetra Bio-Pharma (TSXV: TBP) was the most active symbol on the TSX.V...

Tuesday, November 26, 2019, 02:45:06 PM

Tetra Bio Pharma Strengthens Product Pipeline Via Co-Development Agreement

Tetra Bio Pharma (TSXV: TBP) has strengthened its product pipeline as of this morning, providing...

Thursday, February 27, 2020, 08:53:49 AM

Sylvain Chrétien Appointed President of Tetra Bio Pharma

Tetra Bio Pharma (TSXV: TBP) announced this morning that it has newly created the role...

Tuesday, February 18, 2020, 08:42:26 AM

Tetra Bio-Pharma Cancels $10 Million ATM Financing

It appears that Tetra Bio-Pharma (TSX: TBP) has cold feet when it comes to raising...

Friday, November 5, 2021, 08:56:54 AM